AdvertisementHe Raised Drug Prices at Eli Lilly. This week, Mr. Azar, a former pharmaceutical executive, is expected to face tough questions at a Senate confirmation hearing over why his own company raised prices. And Mr. Azar has struck a conciliatory tone as the public outcry over pharmaceutical prices has grown. Image Mr. Azar was a top executive at the pharmaceutical giant Eli Lilly and Company from 2007 until this January. But in the last year, as public outcry has grown, Mr. Azar has acknowledged a problem.

Source: New York Times November 26, 2017 21:33 UTC